MOFENAC

This brand name is authorized in Nigeria.

Active ingredients

The drug MOFENAC contains one active pharmaceutical ingredient (API):

1	Diclofenac UNII QTG126297Q - DICLOFENAC SODIUM
	Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms.
	Read more about Diclofenac

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8418	Eye drops	MOFENAC EYE DROPS SOL_DROPS 0.1% 110ml	MOFENAC EYE DROPS DICLOFENAC SODIUM 0.1%W/V Diclofenac sodium 0.1%w/v Excipients: Sodium metabisulphite, EDTA Di-Sodium, Sorbic Acid, Boric Acid, Borax, P.E.G -400 A4-8418 Drugs Imported Products 110ml Prescription Only Medicine (POM) 19/04/2022 SKT HEALTHCARE PHARMACEUTICALS LTD, OGUNLOWO ST OFF AWOLOWO WAY IKEJA IKEJA LAGOS 14534862 info@sktpharma.com NITIN LIFESCIENCES LIMITED, RAMPUR GHAT ROAD, PAONTA SAHIB,DISTRICT-SIRMOUR (H.P.)- 173 025, INDIA, India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01BC03	Diclofenac	S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids
Discover more medicines within S01BC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8418